Interestingly, expression of CD276 in the tumor vasculature was significantly correlated with gender, age, T stage, and ENSAT stage in our patient cohort, suggesting that the CD276-invasive rate in the tumor vasculature was higher in either male ACC patients (P = 0.003) or older ACC patients (≥65, P = 0.044). Here, CD276 is linked to neoplasm.